Search Results - "Hittner, Helen Mintz"
-
1
Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy
Published in Ophthalmology (Rochester, Minn.) (01-09-2016)“…Purpose To determine incidence, risk factors, risk period, and characteristics of recurrent retinopathy of prematurity (ROP) treated by intravitreal…”
Get full text
Journal Article -
2
Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II
Published in Retina (Philadelphia, Pa.) (01-06-2008)“…To report a retrospective, consecutive, noncomparative case series of moderate and severe stage 3 retinopathy of prematurity (ROP) in zone I or posterior zone…”
Get full text
Journal Article -
3
Review of effects of anti-VEGF treatment on refractive error
Published in Eye and Brain (01-01-2016)“…To examine the effect of anti-vascular endothelial growth factor (anti-VEGF) agents on refractive error in the setting of retinopathy of prematurity (ROP)…”
Get full text
Journal Article Book Review -
4
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Published in The New England journal of medicine (17-02-2011)“…In this trial, one intravitreal injection of bevacizumab was administered to treat retinopathy of prematurity of stage 3+. Bevacizumab was more effective than…”
Get full text
Journal Article -
5
Avastin as monotherapy for retinopathy of prematurity
Published in Journal of AAPOS (01-02-2010)Get full text
Journal Article -
6
Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity
Published in Journal of AAPOS (01-02-2018)“…Infants with stage 3+ retinopathy of prematurity (ROP) in zone I or zone II posterior were randomized to initial treatment with bevacizumab or laser in a…”
Get full text
Journal Article -
7
Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial
Published in JAMA ophthalmology (01-11-2014)“…Children born prematurely who develop retinopathy of prematurity (ROP) often develop myopia, and those who require laser treatment may develop very high…”
Get more information
Journal Article -
8
Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies
Published in Human mutation (2001)“…Inherited retinopathies are a genetically and phenotypically heterogeneous group of diseases affecting approximately one in 2000 individuals worldwide. For the…”
Get full text
Journal Article -
9
Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors
Published in Early human development (01-12-2012)“…Abstract ROP remains a major cause of childhood blindness worldwide. The smallest, sickest infants develop the most severe forms of zone 1 ROP. Such eyes may…”
Get full text
Journal Article Conference Proceeding -
10
Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes
Published in Journal of AAPOS (01-12-2016)Get full text
Journal Article -
11
Intravitreal pegaptanib as adjunctive treatment for stage 3+ ROP shown to be effective in a prospective, randomized, controlled multicenter clinical trial
Published in European journal of ophthalmology (01-09-2012)“…Both intravitreal pegaptanib with laser therapy and intravitreal bevacizumab monotherapy have been found to be more efficacious than laser therapy alone in…”
Get full text
Journal Article -
12
Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR)
Published in Investigative ophthalmology & visual science (14-05-2012)“…Familial exudative vitreoretinopathy (FEVR) is an inherited disorder that disrupts the development of the retinal vasculature and can result in blindness. FEVR…”
Get full text
Journal Article -
13
Antivascular endothelial growth factor for retinopathy of prematurity
Published in Current opinion in pediatrics (01-04-2009)“…This review will discuss a potentially more effective treatment for retinopathy of prematurity (ROP) with fewer acute and long-term complications. Avastin…”
Get full text
Journal Article -
14
-
15
Mutations in the human forkhead transcription factor FOXE3 associated with anterior segment ocular dysgenesis and cataracts
Published in Human molecular genetics (01-02-2001)“…Dysgenesis of the anterior segment of the eye delineates a spectrum of human developmental disorders that show wide phenotypic and genetic heterogeneity. It is…”
Get full text
Journal Article -
16
A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD
Published in Nature genetics (01-06-1998)“…We report here the identification of a new human homeobox gene, PITX3, and its involvement in anterior segment mesenchymal dysgenesis (ASMD) and congenital…”
Get full text
Journal Article -
17
BEAT-ROP refraction data at age 2 years
Published in Journal of AAPOS (01-02-2013)Get full text
Journal Article -
18
Laser in situ keratomileusis for treated anisometropic amblyopia in awake, autofixating pediatric and adolescent patients
Published in Journal of cataract and refractive surgery (01-12-2004)“…To establish the safety and efficacy of laser in situ keratomileusis (LASIK) in pediatric and adolescent patients with anisometropic amblyopia who completed…”
Get more information
Journal Article -
19
VSX1 (RINX) mutation with craniofacial anomalies, empty sella, corneal endothelial changes, and abnormal retinal and auditory bipolar cells
Published in Ophthalmology (Rochester, Minn.) (01-04-2004)“…To present a previously unreported African American family with 1 variation and 1 mutation of the homeobox transcription factor gene, VSX1 (RINX), and to…”
Get more information
Journal Article -
20
ROP 2012: Laser photocoagulation and bevacizumab—treatment Indications and Long-Term Considerations
Published in Journal of AAPOS (01-02-2012)Get full text
Journal Article